Stock Events

Stock Events

Hikma Pharmaceuticals 

€15.28
0
+€0.27+1.8% Today

Statistics

Day High
15.44
Day Low
15.28
52W High
25.4
52W Low
13.8
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow H5P.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, directly competing with Hikma in the generics and branded drugs markets.
Novartis
NVS
Mkt Cap297.32B
Novartis is a large multinational pharmaceutical company with a strong presence in generic drugs through its Sandoz division, making it a direct competitor to Hikma.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a global pharmaceutical corporation with a broad portfolio that includes generic drugs, competing with Hikma in various therapeutic areas.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, known for its significant research-based pharmaceuticals, competes with Hikma in the specialty pharmaceuticals market, particularly in areas like immunology and oncology.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes with Hikma in the development and marketing of pharmaceuticals for various therapeutic areas.
Merck
MRK
Mkt Cap298.84B
Merck & Co. is a global healthcare company that competes with Hikma in the development, manufacturing, and marketing of pharmaceuticals and vaccines.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that competes with Hikma in the pharmaceutical and vaccines sectors, with a broad portfolio of products.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global pharmaceutical company that competes with Hikma in the areas of generics, specialty care, and vaccines.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Hikma in the development and commercialization of prescription medicines across multiple therapy areas.

About

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Show more...
CEO
H.E Said Samih Taleb Darwazah
Employees
9400
Country
GB
ISIN
GB00B0LCW083

Listings

MX
MX
HIKN.MX
STU
DE
H5P.STU
LSE
GB
HIK.LSE
OTC Link
US
HKMPY

0 Comments

Share your thoughts

FAQ

What is Hikma Pharmaceuticals stock price today?▼
The current price of H5P.STU is €15.28 EUR — it has increased by +1.8% in the past 24 hours. Watch Hikma Pharmaceuticals stock price performance more closely on the chart.
What is Hikma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hikma Pharmaceuticals stocks are traded under the ticker H5P.STU.
Is Hikma Pharmaceuticals stock price growing?▼
H5P.STU stock has risen by +2.2% compared to the previous week, the month change is a +9.5% rise, over the last year Hikma Pharmaceuticals has showed a -28.36% decrease.
How many employees does Hikma Pharmaceuticals have?▼
As of April 10, 2026, the company has 9,400 employees.
In which sector is Hikma Pharmaceuticals located?▼
Hikma Pharmaceuticals operates in the Health Care sector.
When did Hikma Pharmaceuticals complete a stock split?▼
Hikma Pharmaceuticals has not had any recent stock splits.
Where is Hikma Pharmaceuticals headquartered?▼
Hikma Pharmaceuticals is headquartered in London, GB.